Acquisition by Richard Williams of 50000 shares of Adamis Pharma subject to Rule 16b-3
| MME Stock | 0.21 0.01 5.00% |
Slightly above 56% of MoneyMe's investor base is looking to short. The analysis of current outlook of investing in MoneyMe suggests that many traders are alarmed regarding MoneyMe's prospects. MoneyMe's investing sentiment can be driven by a variety of factors including economic data, MoneyMe's earnings reports, geopolitical events, and overall market trends.
MoneyMe |
Filed transaction by Adamis Pharmaceuticals Co director. Grant, award or other acquisition pursuant to Rule 16b-3
Read at macroaxis.com
MoneyMe Fundamental Analysis
We analyze MoneyMe's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MoneyMe using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MoneyMe based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
MoneyMe is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
MoneyMe Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MoneyMe stock to make a market-neutral strategy. Peer analysis of MoneyMe could also be used in its relative valuation, which is a method of valuing MoneyMe by comparing valuation metrics with similar companies.
Peers
MoneyMe Related Equities
| MTO | MotorCycle Holdings | 0.53 | ||||
| ASK | ABACUS STORAGE | 0.86 | ||||
| ERD | EROAD | 0.99 | ||||
| ABB | Aussie Broadband | 1.12 | ||||
| SXL | Southern Cross | 3.17 |
Additional Tools for MoneyMe Stock Analysis
When running MoneyMe's price analysis, check to measure MoneyMe's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MoneyMe is operating at the current time. Most of MoneyMe's value examination focuses on studying past and present price action to predict the probability of MoneyMe's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MoneyMe's price. Additionally, you may evaluate how the addition of MoneyMe to your portfolios can decrease your overall portfolio volatility.